Physician profile
Edward Cheng-Lung Kuan
NPI 1295091155
$89,810.34
in general payments reported to CMS, 2019-2025
13 companies · $19K in 2025
The $19K reported for 2025 was more than what 94% of Otolaryngic Allergy providers received nationally (typical 2025 total: $449).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,262 · 2020: $14K · 2021: $5,084 · 2022: $6,281 · 2023: $23K · 2024: $17K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $51K · Food and Beverage: $4,347 · Travel and Lodging: $2,850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $51,450.79 |
| Food and Beverage | $4,347.13 |
| Travel and Lodging | $2,850.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $58,065.79 | 2019-2025 | Clarifix Cryotherapy Device, N/A, Scopis Ent |
| 3-D Matrix, INC. | $21,281.86 | 2022-2025 | |
| Intersect Ent, INC. | $4,730.27 | 2019-2021 | |
| Medtronic USA, INC. | $1,696.70 | 2019-2020 | |
| Acclarent, INC | $1,396.87 | 2022-2024 | Trudi Nav Cable |
| Medtronic, INC. | $1,210.42 | 2021-2025 | Propel, Stealthstation S8 Platform, Straightshot |
| Integra Lifesciences Corporation | $879.07 | 2024-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Zap Surgical Systems, INC. | $174.61 | 2020 | |
| Neurent Medical Limited | $126.90 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Optinose US, INC. | $100.13 | 2019-2021 | |
| Depuy Synthes Sales INC. | $76.30 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $49.51 | 2025 | Tezspire |
| Ethicon US, LLC | $21.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Kuan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.